z-logo
open-access-imgOpen Access
Photocatalytic Quantum Dot‐Armed Bacteriophage for Combating Drug‐Resistant Bacterial Infection
Author(s) -
Wang Lei,
Fan Xin,
Gonzalez Moreno Mercedes,
Tkhilaishvili Tamta,
Du Weijie,
Zhang Xianlong,
Nie Chuanxiong,
Trampuz Andrej,
Haag Rainer
Publication year - 2022
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202105668
Subject(s) - pseudomonas aeruginosa , bacteriophage , biofilm , microbiology and biotechnology , infectivity , bacteria , chemistry , multiple drug resistance , antibacterial activity , biology , virology , drug resistance , gene , escherichia coli , virus , biochemistry , genetics
Multidrug‐resistant (MDR) bacterial infection is one of the greatest challenges to public health, a crisis demanding the next generation of highly effective antibacterial agents to specifically target MDR bacteria. Herein, a novel photocatalytic quantum dot (QD)‐armed bacteriophage (QD@Phage) is reported for combating green fluorescent protein‐expressing Pseudomonas aeruginosa (GFP‐ P. aeruginosa ) infection. The proposed QD@Phage nanosystem not only specifically binds to the host GFP‐ P. aeruginosa while preserving the infectivity of the phage itself, but also shows a superior capacity for synergistic bacterial killing by phage and by the photocatalytic localized reactive oxygen species (ROS) generated from anchored QD components. Notably, this highly targeted QD@Phage nanosystem achieves robust in vitro antibacterial elimination for both planktonic (over 99.9%) and biofilm (over 99%) modes of growth. In a mouse wound infection model, this system also shows remarkable activity in eliminating the wound infection and promoting its recovery. These results demonstrate that the novel QD@Phage nanosystem can diversify the existing pool of antibacterial agents and inspire the development of promising therapeutic strategies against MDR bacterial infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here